Although it is difficult to draw any conclusions due to the small sample size and short-term follow-up, PIBD patients, including those on anti-TNFα, who completed the third vaccination had no COVID-19 during the observation period, suggesting the efficacy of the third vaccination for the omicron variant, especially B.1.1.529. Here, TNF is linked to COVID-19.